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Radiation Risk Estimation Models
by David G. Hoel*
Cancer risk models and their relationship to ionizing radiation are discussed. There are many model
assumptions and risk factors that have a large quantitative impact on the cancer risk estimates. Other
health end points such as mental retardation may be an even more serious riskthan cancer forthose with
in utero exposures.
Introduction
Besides cigarette smoking, ionizingradiation is prob-
ably the most intensively studied environmental agent
with regard to adverse effects on human health. The
large body ofinformation from the prospective study of
A-bomb survivors in Hiroshima and Nagasaki and data
from several studies ofthe medical diagnostic and ther-
apeutic use ofionizing radiation provide us with a great
deal of human exposure data. The A-bomb survivor
group represents the largest single study, with well
over 120,000 individuals who have been followed pro-
spectively since 1950. Much of our collective knowledge
ofradiation health effects in man has been based on this
study. This particular effort in turn serves as a model
for other environmental agents and suggests important
issues that we must address.
Carcinogenesis and genetic effects are believed to be
the primary effects of radiation. In the A-bomb survi-
vors, carcinogenesis has certainly been established.
However, genetic effects have notbeen observed inthis
population (1). This apparent genetic soundness is a
surprise to many, since our understanding of mecha-
nisms and results of experimental studies imply that
radiation should indeed be a mutagen. The lack of ge-
netic aberrations intheA-bomb survivors indicatesthat
man may be more resistant to ionizing radiation than
are laboratory animals. This is indeed welcome news.
Onthe otherhand, carcinogenesis ispresentinthe same
population and demonstrates that radiation affects a
large number of various cancers and cancer sites.
Radiation Cancer Models
Radiation-induced cancersfollow one oftwofairlydis-
tinct patterns. We observe the first pattern with the
leukemias. These cancers begin to occur after a short
latency period, sometimes as short as 2 years since ex-
posure. The leukemia incidence rate approaches a max-
*Division ofBiometry and Risk Assessment, National Institute of
Environmental Health Sciences, Research Triangle Park, NC 27709.
imum after 5 to 10 years. About 20 years postexposure
the rates decline to little or no effect. The rates are
quitehighcomparedtospontaneousratesandarethere-
fore easily detectable. The other primary cancers that
have produced sufficient dataformodelingpurposes are
those ofthe lung, breast, stomach, and thyroid. These
particular cancers are not observed until much of the
leukemia has already begun to decline. In particular, it
appears that there is at least a 10-year latency period,
and that the cancers follow the pattern of a constant,
increased relative risk. This in turn implies that the
number of excess cancers at any site due to radiation
increases with increasing time since exposure. Spon-
taneous cancer rates also follow this pattern (2).
The relative risk effect is not constant for a given
amount ofradiation in relation to the spontaneous rate.
Instead, it tends to behave in an additive manner for a
given cancer site. The evidence for this is based pri-
marily upon the results observed in breast cancer. The
spontaneous rate of breast cancer in the Japanese is
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X-irradiation. Data from Norton and Donoso (8).
much lower than in the U.S., yet the amou
cancer induced per unit of radiation tend
proximately the same between the two I
This implies that we are dealing with const
risk within a population, with an additive ri
existing between populations for a given
This finding is an important tool for extrap
between human population groups (3).
Another important observation that has
in the A-bomb survivors is that of age and
tibility in relation to carcinogenic effects. F
leukemia cancers, one observes that the rih
withdecreasingage-at-exposure. Byincreas
mean the cancer risk at a given age of the
Of course, the older individual is at higher
ured in duration since exposure) because t
based on a relative risk. However, the t(
carcinogenic effectmaybeanorderofmagnitudehigher
for a child than for a 50-year-old adult.
The in utero-exposed may possibly be the most sus-
ceptible group ofall. It has onlybeen 40 years since the
Hiroshima-Nagasaki in utero group was exposed, and
the excess cancers arejustbeginning to appear. It will
be another 20 years or so before this issue of in utero
susceptibility is clarified. The question ofage-at-expo-
sure has obvious implications to risk analyses where
one uses occupational-exposed groups of limited dura-
tion to estimate environmental lifetime cancer risk for
the generalpopulation and vice versa. There are similar
implications regarding the analyses of animal carcino-
genicity studies andtheircomparisontoepidemiological
50 data. The chemical carcinogens data are most often de-
rived from occupational exposures.
Dose-Response Relationships
utwroAeUxoU Dose and dose rate present particularly proble-
ita from Otake
matical issue for risk estimation of ionizing radiation.
The data from Hiroshima and Nagasaki are su-ch that
we do not observe statistically significant cancer effects
for individuals in the dose groups exposed to less than
50rads. Thisis primarilydue tosample sizeandrandom
variability. As such, we cannot determine the shape of
the dose-response curve at the lower doses based on
epidemiological data. Ideally, we would like to consider
risks at the 0.1 to 1 rad range. To dothis, however, we
must depend upon experimental studies and hypothet-
ical models for the shape ofthe dose-response curve for
the particular cancer sites of interest. In studying the
shape ofthe dose-response relationships in animal stud-
ies, we see that at higher doses cell killing takes place,
and there is in fact a reversal in the dose-response re-
lationship. This is due to the increased likelihood of
death of cancerous cells at increased dose levels. This
has been clearly demonstrated by Upton in the RF
mouse (4). The same effect has also been observed in
after prenatal some human studies. For example, analyses conducted
by Land on A-bomb survivors have included a cell-kill-
ing term that has an effect on the highest dose groups
nt ofbreast (5). Instudiesoftherapeuticradiation atextremelyhigh
Is to be ap- exposure levels, we do not observe subsequent cancers
populations. that we would have predicted from an ordinary linear
;ant relative dose-response relationship. Thusit has beenfairlywell-
isk situation established that cell Illinglowers the cancerrisk atthe
cancer site. higher dose levels.
olating data At the low dose levels, there is considerable debate
abouttheshape ofthedose-response curve. Possibilities
been made are linear, nonlinear, threshold, and hormesis, which
sex suscep- gives a protective effect. At the 1 rad level, whether
ior the non- one uses a linear dose-response function or a purely
sk increases quadratic dose-response function with an exponential
;ingrisk, we cell-killing term, the risk differs by two orders of mag-
individual. nitude (6). The problem is that based upon observed
risk (meas- cancer data we cannot differentiate between these two
the effect is possible curves, since a purely quadratic dose response
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shown to closely approach a simple linear relationship.
This phenomenon is illustrated in Figure 1. Even with
the large sets of epidemiological data and rodent car-
cinogenicity studies, the issue oflow-dose radiation ef-
fects is notresolved. Hence, thereislittle prospect that
the risk estimation for particular chemical carcinogens
would be any more precise.
A biological marker that can be measured, either in
individuals or in biological systems, is needed to better
represent the possible linearity or nonlinearity ofdose-
response relationships. The issue of cell killing also
raises the possibilitythat for some ofthe chemicals that
havebeentested, thehighestdose studied mayproduce
less cancer than an intermediate level, even after ap-
propriate adjustments are made for competing mortal-
ity. While the initial reaction to these chemical studies
that produce nonmonotonic responses may be to regard
the data as potentially unreliable, experience for the
field ofradiation suggests instead that the lack ofmon-
otonicity may well be due to cell killing.
Noncancer End Points
Environmental studies have focused primarilyoncar-
cinogenic effects. Other issues such as reproduction,
neurological, and immunological effects have received
less attention, but may in some instances be ofequal or
greater importance in assessing the impact of health
hazards. Again, ionizing radiation provides us with an
important example. In Figure 2, data on the incidence
of severe mental retardation are shown for individuals
who received exposure at approximately 8 to 15 weeks
ofgestational age. The limited available data indicate a
highrisk and do not suggest thepresence ofathreshold
level. Animal studies have also been carried out, and in
Figure 3, data are given that indicate the possible lack
of a threshold level. The data presented by Otake and
Schull (7) for mental retardation in the A-bomb survi-
vors indicate fetal dose, which is approximately 40% of
the external dose. Forcomparative purposes, the doses
shown in Figure 2 should then be increased by a factor
of2.5. Assuming linearity, an external dose of 1 rad to
the fetus would result in approximately 200 cases per
105(basedupon36%incidence at72radfetaldose). This
is compared with an estimated 20 to 100 cases per 10r
for total cancers for an age-at-exposure of0 to 9 years
(6). By equating severe retardation with cancer mor-
tality we see a greater risk of retardation per unit of
exposure.
In summary, we have shown, albeit superficially, the
complexity of human health effects with regard to a
single agent that has been examined extensively both
in human populations and in laboratory animals. This
review also shows the complexity of human risk esti-
mation and suggests some particular issues that should
be addressed when considering studies of other envi-
ronmental agents; in particular, questions of dose re-
sponse, age and sex susceptibility, and end points other
than the traditional one of carcinogenesis.
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